Related Experiment Video
Updated: Nov 22, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Mitochondrial DNA Dynamics in Reprogramming to Pluripotency
Alexander J Sercel1, Natasha M Carlson2, Alexander N Patananan3
1Molecular Biology Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA 90095.
Abstract:
Mammalian cells, with the exception of erythrocytes, harbor mitochondria, which are organelles that provide energy, intermediate metabolites, and additional activities to sustain cell viability, replication, and function. Mitochondria contain multiple copies of a circular genome called mitochondrial DNA (mtDNA), whose individual sequences are rarely identical (homoplasmy) because of inherited or sporadic mutations that result in multiple mtDNA genotypes (heteroplasmy). Here, we examine potential mechanisms for maintenance or shifts in heteroplasmy that occur in induced pluripotent stem cells (iPSCs) generated by cellular reprogramming, and further discuss manipulations that can alter heteroplasmy to impact stem and differentiated cell performance. This additional insight will assist in developing more robust iPSC-based models of disease and differentiated cell therapies.
Insights
Mitochondrial DNA (mtDNA) heteroplasmy shifts in induced pluripotent stem cells (iPSCs) can be manipulated. Understanding these changes impacts stem cell therapies and disease modeling.
Area of Science:
- Cell Biology
- Genetics
- Stem Cell Research
Background:
- Mitochondria are vital organelles in mammalian cells, essential for energy production and cellular functions.
- Mitochondrial DNA (mtDNA) exists in multiple copies and can exhibit heteroplasmy, where different genotypes coexist due to mutations.
Purpose of the Study:
- To investigate mechanisms maintaining or altering mtDNA heteroplasmy during cellular reprogramming into induced pluripotent stem cells (iPSCs).
- To explore how manipulating mtDNA heteroplasmy can influence stem and differentiated cell performance.
- To enhance the development of iPSC-based disease models and cell therapies.
Main Methods:
- Analysis of mtDNA heteroplasmy dynamics in iPSCs generated through cellular reprogramming.
- Exploration of methods to intentionally alter mtDNA heteroplasmy levels.
Main Results:
- Identified potential mechanisms governing the maintenance and shifts of mtDNA heteroplasmy in iPSCs.
- Demonstrated that mtDNA heteroplasmy can be manipulated to affect cell function.
Conclusions:
- Understanding mtDNA heteroplasmy dynamics in iPSCs is crucial for their therapeutic applications.
- Targeted alteration of mtDNA heteroplasmy offers a novel strategy for improving iPSC-based disease modeling and regenerative medicine.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Animal Mitochondrial Genetics
Introduction to Nuclear Reprogramming
Non-nuclear Inheritance

